Agilent Technologies Inc. announced today its participation at the American Association for Cancer Research (AACR) Annual Meeting on April 25-30, 2025 in Chicago, Illinois. Innovative Agilent products ...

In January 2023, Agilent Technologies recently acquired Avida Biomed, a startup life science company that develops high-performance target-enrichment techniques with unique capabilities for clinical ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

A rough start to 2025 has pulled the US stock market down more than 8%, pushing dozens of stocks into undervalued territory.

European certification for PD-L1 IHC 22C3 pharmDx to help gastric or GEJ adenocarcinoma patients for KEYTRUDA® therapy SANTA ...

The PD-L1 IHC 22C3 PharmDx (Code SK006) assay is now certified for use to aid treatment decisions for patients with gastric or gastroesophageal junction adenocarcinoma.

Agilent Technologies Inc. (NYSE: A) will release financial results for the second quarter of fiscal year 2025 after the stock ...

Bioprocess Analyzers Market As per MRFR analysis, the Bioprocess Analyzers Market Size was estimated at 2.28 (USD Billion) in 2023. US, ...

Request To Download Free Sample of This Strategic Report @- However, high cost of instruments and lack of trained professionals impede the market growth. Epigenetics is a stream of genetics that ...

The "Gas Chromatography Market - A Global and Regional Analysis: Focus on End-Use Sectors, Products, and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's ...

GEM Hospital on Wednesday officially launched a surgical instrument that enables surgeons to perform procedures with less instrument exchanges, less blood loss and minimal tissue damages.